Skip to Main content Skip to Navigation
Journal articles

Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine

Abstract : The main cause of death from cancer is associated with the development of metastases, resulting from the inability of current therapies to cure patients at metastatic stages. Generating preclinical models to better characterize the evolution of the disease is thus of utmost importance, in order to implement effective new cancer biomarkers and therapies. Circulating Tumor Cells (CTCs) are good candidates for generating preclinical models, making it possible to follow up the spatial and temporal heterogeneity of tumor tissues. This method is a non-invasive liquid biopsy that can be obtained at any stage of the disease. It partially summarizes the molecular heterogeneity of the corresponding tumors at a given time. Here, we discuss the CTC-derived models that have been generated so far, from simplified 2D cultures to the most complex CTC-derived explants (CDX models). We highlight the challenges and strengths of these preclinical tools, as well as some of the recent studies published using these models.
Complete list of metadata

Cited literature [121 references]  Display  Hide  Download
Contributor : Dominique Heymann Connect in order to contact the contributor
Submitted on : Monday, December 24, 2018 - 1:37:26 PM
Last modification on : Wednesday, April 27, 2022 - 3:57:07 AM
Long-term archiving on: : Monday, March 25, 2019 - 1:13:21 PM


manuscript.v8 unmarked.pdf
Publisher files allowed on an open archive




Marta Tellez-Gabriel, Denis Cochonneau, Marie Cadé, Camille Jubelin, Marie-Françoise Heymann, et al.. Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine. Cancers, MDPI, 2018, 10, epub ahead of print. ⟨10.3390/cancers11010019⟩. ⟨inserm-01964962⟩



Record views


Files downloads